| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.09 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.07 | 0.09 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |